The largest price reduction is for methotrexate, a rheumatoid arthritis drug that can also be used for multiple cancers, which saw a 54 percent price difference.
Here are the price drops:
1. Allopurinol 300 milligram — $8.40 for 90 tablets (was $12)
2. Cinacalcet HCl 60 milligram — $53.40 for 90 tablets (was $57)
3. Dabigatran etexilate mesylate 150 milligram — $646.50 for 90 capsules (was $674.40)
4. Etodolac 200 milligram — $19.20 for 90 capsules (was $24.60)
5. Etodolac 300 milligram — $21.90 for 90 capsules (was: $29.10)
6. Fluconazole 100 milligram — $21 for 90 tablets (was $30)
7. Finasteride 1 milligram — $6.60 for 90 tablets (was $7.50)
8. Hydrocortisone perianal 2.5% — $7.60 for 30 gram tube of cream (was $9.90)
9. Methotrexate 2.5 milligram — $12 for 90 tablets (was $26.40)
10. Nebivolol HCl 2.5 milligram — $12 for 90 tablets (was $13.80)
11. Prazosin HCl 1 milligram — $14.70 for 90 capsules (was $21.90)
12. Prazosin HCl 2 milligram — $18.30 for 90 capsules (was $22.80)
13. Prazosin HCl 5 milligram — $26.40 for 90 capsules (was $35.40)
14. Paroxetine 10 milligram — $5.70 for 90 tablets (was $6.60)
15. Ranolazine extended release 500 milligram — $15.60 for 90 tablets (was $14.70)
16. Tenofovir disoproxil fumarate 300 milligram — $47.10 for 90 tablets (was $48.90)
17. Valsartan 320 milligram — $21.90 for 90 tablets (was $19.20)
18. Valsartan-hydrochlorothiazide 80 milligram/12.5 milligram — $20.10 for 90 tablets (was $22.80)
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
